Across TCGA pan-cancer cohorts, RNU1-56P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU1-56P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU1-56P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU1-56P is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA, KIRC, and COAD are the cancer types where RNU1-56P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-56P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	IV	−0.570	.001	4	view →
KIRC	All	All	+0.081	.022	4	view →
COAD	Female	IV	+0.865	.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU1-56P RNA expression & survival · all RNU1-56P data types